Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
HR2623119th CongressWALLET
Innovative Therapies Centers of Excellence Act of 2025
Sponsored By: Representative Correa, J. Luis [D-CA-46]
In Committee
Summary
Creates a network of at least five VA "innovative therapies centers of excellence" to research, train clinicians, and deliver psychedelic and other novel treatments for specified conditions. This law builds a geographically distributed system that links clinical care, research, and education around therapies like psilocybin, ketamine, MDMA, and others designated by the VA.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Funding and expert review for VA centers
The bill would authorize $30 million each year for research and education at these centers. Congress would still need to appropriate the money, and the VA health leader could move some existing medical and research funds to help the centers. The VA would set up a panel of innovative‑therapy experts to score site proposals and advise the VA health leader. Half the members would serve three‑year terms and half two‑year terms. The panel would not be subject to chapter 10 of title 5. The VA would report to Congress each year on the centers’ activities and findings.
New VA centers for innovative therapies
If enacted, VA would pick at least five medical centers as Innovative Therapies Centers of Excellence. Centers would open only if Congress provides money. Sites would be chosen after expert peer review. Each site would need ties to accredited medical, psychiatry, and social work schools, with training for residents. The centers would target PTSD, depression, anxiety, chronic pain, Parkinson's, and substance use. Therapies could include MDMA, psilocybin, ketamine, 5‑MeO‑DMT, and ibogaine, and the VA could add more. VA would spread centers across regions, coordinate care and research, build provider networks, keep a national data repository, and include a veterans advisory group.
Sponsors & CoSponsors
Sponsor
Correa, J. Luis [D-CA-46]
CA • D
Cosponsors
Rep. Bergman, Jack [R-MI-1]
MI • R
Sponsored 4/3/2025
Rep. Crenshaw, Dan [R-TX-2]
TX • R
Sponsored 4/3/2025
Rep. Khanna, Ro [D-CA-17]
CA • D
Sponsored 4/3/2025
Rep. Luttrell, Morgan [R-TX-8]
TX • R
Sponsored 4/3/2025
Rep. Swalwell, Eric [D-CA-14]
CA • D
Sponsored 4/7/2025
Rep. Lee, Susie [D-NV-3]
NV • D
Sponsored 4/7/2025
Rep. Elfreth, Sarah [D-MD-3]
MD • D
Sponsored 5/5/2025
Rep. Wied, Tony [R-WI-8]
WI • R
Sponsored 5/6/2025
Rep. Budzinski, Nikki [D-IL-13]
IL • D
Sponsored 6/30/2025
Rep. Barrett, Tom [R-MI-7]
MI • R
Sponsored 7/10/2025
Rep. Schrier, Kim [D-WA-8]
WA • D
Sponsored 7/25/2025
Rep. Fields, Cleo [D-LA-6]
LA • D
Sponsored 9/10/2025
Rep. Van Drew, Jefferson [R-NJ-2]
NJ • R
Sponsored 9/11/2025
Rep. Pfluger, August [R-TX-11]
TX • R
Sponsored 9/23/2025
Rep. Suozzi, Thomas R. [D-NY-3]
NY • D
Sponsored 9/26/2025
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 10/3/2025
Rep. Thompson, Bennie G. [D-MS-2]
MS • D
Sponsored 10/3/2025
Rep. Thompson, Mike [D-CA-4]
CA • D
Sponsored 11/4/2025
Rep. Lofgren, Zoe [D-CA-18]
CA • D
Sponsored 11/17/2025
Rep. Barr, Andy [R-KY-6]
KY • R
Sponsored 11/17/2025
Rep. Ruiz, Raul [D-CA-25]
CA • D
Sponsored 12/1/2025
Rep. Lawler, Michael [R-NY-17]
NY • R
Sponsored 1/6/2026
Rep. Massie, Thomas [R-KY-4]
KY • R
Sponsored 2/25/2026
Del. Radewagen, Aumua Amata Coleman [R-AS-At Large]
AS • R
Sponsored 3/16/2026
Rep. Vargas, Juan [D-CA-52]
CA • D
Sponsored 4/6/2026
Rep. McBride, Sarah [D-DE-At Large]
DE • D
Sponsored 4/9/2026
Rep. Kiggans, Jennifer A. [R-VA-2]
VA • R
Sponsored 4/20/2026
Rep. Kean, Thomas H. [R-NJ-7]
NJ • R
Sponsored 8/13/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov